"British regulators approved the trial in just 17 days, and the testing company, based in Massachusetts, did not have an adequate response plan in the event of a disastrous adverse reaction, British investigators concluded."
This seems like a bit of an issue.
EDIT: Not the same trial, I'm a fool.